620P MGC018, an anti-B7-H3 antibody-drug conjugate (ADC), in patients with advanced solid tumors: Preliminary results of phase I cohort expansion

Autor:	J. Cortés, C. Paller, I. Lugowska, Eugene Shenderov, Andrew Weickhardt, G. Mallesara, Wen Xu, S. Jang, J. Shen, C. Bohac, Nicholas J. Vogelzang, Rodryg Ramlau, J. Zolnierek, Alexander I. Spira, J. Powderly, Emmanuel S. Antonarakis, P.J. Wysocki, J. Aragon-Ching, K. Leu, Anthony M. Joshua
Rok vydání:	2021
Předmět:	Oncology medicine.medical_specialty Antibody-drug conjugate business.industry Internal medicine Phase (matter) Cohort medicine In patient Hematology business
Zdroj:	Annals of Oncology. 32:S657-S659
ISSN:	0923-7534
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::a223e8cbdbdb5ee1f689fc69251ffe8b https://doi.org/10.1016/j.annonc.2021.08.1133 Zobrazit plný text záznamu